Viralgen and Axovia Therapeutics are set to form a partnership to progress the development and manufacturing of an adeno-associated virus vector serotype 9 (AAV9)-based gene therapy for retinal ...

Researchers from Tikkunlev Therapeutics Inc. and the University of Utah have presented preclinical data on TLT-101, a gene therapy consisting of an adeno-associated virus serotype 9 (AAV9) vector ...

Bio-Rad Laboratories, Inc has introduced Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 ...

achieve up to 1,000-fold higher RNA expression in the brain and 100-fold higher RNA expression in the spinal cord of NHPs relative to AAV9, which is the naturally occurring AAV serotype that is ...

A recombinant AAV9 capsid shell able to deliver payload across the blood-brain barrier and into the nervous system and many other tissues · Self-complementary (sc) AAV DNA technology, featuring ...

Together with the existing Vericheck ddPCR Empty-Full Capsid Kits for serotypes AAV5 and AAV9, the addition of the new kits for ... with AAV2 being the most prevalent serotype in clinical trials. Each ...